Live Breaking News & Updates on மகேஷ் கறந்தே

Stay updated with breaking news from மகேஷ் கறந்தே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Omega Therapeutics Strengthens Board of Directors with Appointment of R&D Veteran Elliott M. Levy, M.D.


Share this article
Share this article
CAMBRIDGE, Mass., May 20, 2021 /PRNewswire/ Omega Therapeutics, Inc. ( Omega ), a development-stage biotechnology company leveraging its OMEGA Epigenomic Programming™ platform to harness the power of epigenetics and pioneer novel DNA-sequence-based targets and develop a new class of mRNA-encoded programmable epigenetic medicines, today announced the appointment of Elliott M. Levy, M.D., to its Board of Directors. Dr. Levy is an industry veteran with over 20 years of research and development experience at global pharmaceutical companies, including Amgen and Bristol-Myers Squibb.
Elliott s extensive leadership experience in spearheading research and development strategy and operations at all stages of clinical development is a valuable addition to our team as we focus our efforts on further expanding the potential of our OMEGA platform across a broad array of diseases. Through his professional career at major pharmaceutical comp ....

United Kingdom , Robert Wood Johnson , David Rosen , Joseph Rayne , Mahesh Karande , Bristol Myers Squibb , Noubar Afeyan , Head Of Specialty Development At Bristol Myers Squibb , Yale School Of Medicine , Global Development At Amgen , Prnewswire Omega Therapeutics Inc , Transcelerate Biopharma Inc , Renal Division At Brigham , Omega Epigenomic , Chief Executive Officer , Omega Therapeutics , Senior Vice President , Global Development , Specialty Development , Renal Division , Board Chair , Transcelerate Biopharma , Yale School , Chief Medical Resident , Robert Wood Johnson Clinical Scholars , Insulated Genomic Domains ,